Clinical trial
Patients at High Risk for Postoperative Nausea and Vomiting Undergoing Gynecological Surgery: Efficacy of Oral Amisulpride in Combination With Intravenous Ondansetron and Dexamethasone - a Parallel-group Randomized Trial
NCT06887621 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patients at High Risk for Postoperative Nausea and Vomiting Undergoing Gynecological Surgery: Efficacy of Oral Amisulpride in Combination With Intravenous Ondansetron and Dexamethasone - a Parallel-group Randomized Trial
- Lead sponsor
- Instituto do Cancer do Estado de São Paulo
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- April 10, 2025
- Completion date
- March 31, 2027
- Enrollment
- 276 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post operative nausea and vomiting (ponv)